RSS Feed

Using Genetics to Target Cancer's Achilles' Heel

To develop more effective treatments for cancer, doctors are zeroing in on the disease's genetic drivers. John DiPersio, chief of oncology at Washington University Medical Center, and Merck's Gary Gilliland discuss how this may revolutionize the future of cancer treatment.

The Buzz On Silent Retreats

If you feel bombarded by emails, phone calls, text messages and the daily stress that comes with them, there could be a solution for you. Some people have found relief in perfect silence. Host Michel Martin learns more about the popularity of silent retreats.

How Military Research On Anthrax Could Lead To A Weapon Against Gluten

Anthrax spores and gluten are health problems on a very different scale. But researchers believe they both could be vulnerable to thoughtfully designed enzymes. Computerized tools funded by the Defense Department to develop countermeasures for chemical and biological attacks may help with a treatment for celiac disease.

Merck Halts Sale Of Niacin Drug In 40 Countries

Tredaptive was never approved in the U.S., but it has been sold in many countries around the world. A large, international study found the drug did not reduce the risk of heart disease and stroke, yet did trigger some serious side effects.

Feeling Miserable? You're Not Alone, And The Flu Epidemic Has Yet To Peak

Across the nation, many Americans are suffering from an outbreak that has hit hard and hit early. Hospitals are jammed and many places are running out of vaccine. The flu's already been blamed for the deaths of at least 20 children.

Haiti Then And Now: 3 Years After The Earthquake

Evidence of loss remains even three years after a massive earthquake claimed the lives of as many as 200,000 people in Haiti. One of the first photojournalists to capture the grim aftermath of the quake, NPR's David Gilkey traveled back to Haiti to revisit images he originally took in 2010.